Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Everett, WA
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Everett, WA
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Huntington, WV
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntington, WV
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Buenos Aires,
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Kansas City, MO
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Univ. of Florida College Medicine
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Unit of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Port Orange, FL
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Sinai Center for Thrombosis Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Rapid City, SD
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Black Hills Cardiovascular Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
West Houston Area Clinical Trial Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Katy, TX
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
Cardiology Center of Houston
mi
from
Katy, TX
Click here to add this to my saved trials
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated:  12/31/1969
mi
from
Heath Park,
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease: 2nd Switching Antiplatelet Agents
Status: Enrolling
Updated: 12/31/1969
University Hospital of Wales
mi
from
Heath Park,
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Huntsville, AL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Huntsville Hospital - The Heart Center, PC
mi
from
Huntsville, AL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Jonesboro, AR
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
NEA Baptist Memorial Hospital
mi
from
Jonesboro, AR
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Jonesboro, AR
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. Bernard's Medical Center
mi
from
Jonesboro, AR
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Loma Linda, CA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Sacramento, CA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Mercy General Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Newark, DE
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Brandon, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Brandon Regional Hospital
mi
from
Brandon, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Gainesville, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
North Florida Regional Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Hollywood, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami Beach, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Orlando, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Orlando Regional Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Panama City, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Bay Medical Center
mi
from
Panama City, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Stuart, FL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Martin Memorial Health Systems - Martin Memorial Medical Center
mi
from
Stuart, FL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Atlanta, GA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Macon, GA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Coliseum Medical Center
mi
from
Macon, GA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Quincy, IL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Blessing Hospital
mi
from
Quincy, IL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Indianapolis, IN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Franciscan St. Francis Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. Joseph Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Shreveport, LA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Research, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Bangor, ME
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Hyannis, MA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Cape Cod Hospital
mi
from
Hyannis, MA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Coon Rapids, MN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Minneapolis, MN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
North Memorial Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Hattiesburg, MS
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Forest County General Hospital
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Springfield, MO
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Cox Medical Centers
mi
from
Springfield, MO
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Springfield, MO
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. John's Regional Health Center (Springfield)
mi
from
Springfield, MO
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Hackensack, NJ
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Utica, NY
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. Elizabeth Medical Center
mi
from
Utica, NY
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Tulsa, OK
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Doylestown, PA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Presbyterian University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Greenville, SC
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
University Medical Center-Greenville Memorial Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Greenville, SC
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
St. Francis Health System - St. Francis Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Myrtle Beach, SC
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Rapid City, SD
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from
Sioux Falls, SD
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Avera Heart Hospital of South Dakota
mi
from
Sioux Falls, SD
Click here to add this to my saved trials